HER2 Support Group Forums - View Single Post - Lilly announces new data from two Phase II ramucirumab trials on NSCLC

News · 10-01-2012, 02:00 AM

Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).

More...

10-01-2012, 02:00 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,123	Lilly announces new data from two Phase II ramucirumab trials on NSCLC Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC). More...